PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24992758-8 2014 Serum levels of TNF-alpha, IL-2, and IFN-gamma, frequencies of CD4 + and CD8+ T cells in the spleen, and splenic NK and CTL activities were also significantly increased in mice treated with 5-FU+PL or 5-FU+PTM compared with mice treated with 5-FU alone (P < 0.05). pl 195-197 tumor necrosis factor Mus musculus 16-25 26588227-9 2015 The pro-inflammatory cytokine expression in the mouse colon, including TNF-alpha, IL-6, INF-gamma, IL-17, and IL-1beta, was significantly up-regulated by DSS treatment, but was inhibited upon PL administration. pl 192-194 tumor necrosis factor Mus musculus 71-80 34802947-11 2021 Moreover, the anti-inflammatory effect of PL was evidenced by the maintenance of AnxA1 levels, reduction of COX-2 (p < 0,05), Bcl-2 (p < 0,01) and NF-kB (p < 0,001) expressions and decreased IL-1beta, IL-17 (p < 0,01) and TNF-alpha (p < 0,05) levels. pl 42-44 tumor necrosis factor Mus musculus 222-231 22249932-3 2012 RESULTS: PL caused peribronchial and perivascular inflammation that peaked at 18-24 h. Polymorphonuclear cells (PMNs) began to accumulate in bronchoalveolar lavage fluid (BALF) of PL-challenged mice by 4 h and accounted for >90% of leukocytes by 18-24 h. Inflammation was marked by the appearance of MIP-2, KC, TNF-alpha, and IL-6 in the BALF with peak levels attained 4 h after PL administration. pl 9-11 tumor necrosis factor Mus musculus 314-323